Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 1,069,108 shares at $100.94 ($109.6M) on 2020-09-17, disclosed to the SEC on 2020-09-17.
Open-market sale of $109.6M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.21 | 37,474 | $3.8M | 3.5% |
| 2 | $102.21 | 37,474 | $3.8M | 3.5% |
| 3 | $103.30 | 29,785 | $3.1M | 2.8% |
| 4 | $103.30 | 29,785 | $3.1M | 2.8% |
| 5 | $104.04 | 42,106 | $4.4M | 4.0% |
| 6 | $104.04 | 42,106 |
| $4.4M |
| 4.0% |
| 7 | $104.79 | 683 | $72K | 0.1% |
| 8 | $104.79 | 683 | $72K | 0.1% |
| 9 | $103.05 | 43,351 | $4.5M | 4.1% |
| 10 | $103.05 | 43,351 | $4.5M | 4.1% |
| 11 | $104.07 | 152,011 | $15.8M | 14.4% |
| 12 | $104.07 | 152,011 | $15.8M | 14.4% |
| 13 | $104.61 | 23,147 | $2.4M | 2.2% |
| 14 | $104.61 | 23,147 | $2.4M | 2.2% |
| 15 | $99.16 | 8,570 | $850K | 0.8% |
| 16 | $99.16 | 8,570 | $850K | 0.8% |
| 17 | $100.02 | 76,084 | $7.6M | 6.9% |
| 18 | $100.02 | 76,084 | $7.6M | 6.9% |
| 19 | $100.94 | 111,591 | $11.3M | 10.3% |
| 20 | $100.94 | 111,591 | $11.3M | 10.3% |
| 21 | $102.10 | 9,728 | $993K | 0.9% |
| 22 | $102.10 | 9,728 | $993K | 0.9% |
| 23 | $102.82 | 48 | $5K | 0.0% |
| Total | $102.49 avg | 1,069,108 | $109.6M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |